Page last updated: 2024-09-05

deflazacort and Deafness, Sudden

deflazacort has been researched along with Deafness, Sudden in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Álvarez-Cañas, C; Álvarez-Cuenllas, B; Jiménez, M; Jorquera, F; Linares, P; Monteserín, L; Rodríguez-Martín, L1
Atzori, L; Bandino, F; Carta, F; Chuchueva, N; Fanos, V; Lussu, M; Noto, A; Peppi, M; Puxeddu, R1
Blasco Huelva, A; González Palomino, A; Marcos García, M; Montero García, C; Pantoja Hernández, CG; Pardo Romero, G; Pino Rivero, V; Trinidad Ruíz, G1

Reviews

1 review(s) available for deflazacort and Deafness, Sudden

ArticleYear
Acute hepatitis secondary to high-dose intravenous methylprednisolone.
    Gastroenterologia y hepatologia, 2018, Volume: 41, Issue:8

    Topics: Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Drug Therapy, Combination; Female; Hearing Loss, Sudden; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Pregnenediones

2018

Other Studies

2 other study(ies) available for deflazacort and Deafness, Sudden

ArticleYear
Metabolomic analysis of urine with Nuclear Magnetic Resonance spectroscopy in patients with idiopathic sudden sensorineural hearing loss: A preliminary study.
    Auris, nasus, larynx, 2017, Volume: 44, Issue:4

    Topics: 3-Hydroxybutyric Acid; Adolescent; Adult; Aged; Alanine; Anticoagulants; Audiometry, Pure-Tone; Case-Control Studies; Child; Citric Acid; Cohort Studies; Creatinine; Enoxaparin; Female; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Immunosuppressive Agents; Male; Metabolomics; Methylamines; Middle Aged; Pregnenediones; Prognosis; Prospective Studies; Proton Magnetic Resonance Spectroscopy; Urine; Young Adult

2017
[Statistical study and clinical results by comparison of two different protocols in the treatment of sudden hearing loss].
    Acta otorrinolaringologica espanola, 2005, Volume: 56, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Clinical Protocols; Drug Administration Schedule; Drug Therapy; Enzyme Inhibitors; Female; Hearing Loss, Sudden; Humans; Male; Methylprednisolone; Middle Aged; Nootropic Agents; Piracetam; Pregnenediones

2005